HPV, the human papilloma virus, is a cause of genital warts and cervical cancer. 人乳头状瘤病毒(HPV),是一种导致生殖器肿瘤和宫颈癌的病毒。
The researchers tested for safety and immune response using two vaccines, one based on an experimental HIV vaccine and the other a human papilloma virus ( HPV ) vaccine. 这组科学家利用两种疫苗测试了安全性和免疫应答,一种疫苗是基于一种实验中的艾滋病疫苗,另一种是基于人乳头状瘤病毒(HPV)疫苗。
Objective To research human papilloma virus ( HPV ) infection status in human immunodeficiency virus ( HIV ) positive people and in HIV negative people in Shenzhen city. 目的了解深圳市人类免疫缺陷病毒(HIV)阳性及阴性人群中人乳头瘤病毒(HPV)感染情况。
Vaccination against the human papilloma virus ( HPV ), the main cause of cervical cancer, is an option to further reduce incidence. 人乳头瘤病毒(HPV)是导致子宫颈癌的首要病因,针对该病毒的免疫接种是进一步降低发病率的一种方案。
Relationship of high risk human papilloma virus and cervical cancer and precancer 高危型人乳头瘤病毒测定与宫颈癌及其癌前病变的关系